May 5, 2017 10:09 AM EDT
News Briefing

Gates Foun­da­tion fu­els Achao­gen’s an­ti­body plat­form with $20.5M com­mit­ment; Igny­ta rais­es $77M

Shehla Shakoor

Managing Director

→ The Bill & Melin­da Gates Foun­da­tion has come in with a ma­jor as­sist at Achao­gen $AKAO. The non­prof­it will in­vest $10 mil­lion in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times